Cell-Based Ligand Discovery for the ENL YEATS Domain

ENL is a transcriptional coactivator that recruits elongation machinery to active cis-regulatory elements upon binding of its YEATS domaina chromatin reader moduleto acylated lysine side chains. Discovery chemistry for the ENL YEATS domain is highly motivated by its significance in acute leukemia...

Full description

Saved in:
Bibliographic Details
Published inACS chemical biology Vol. 15; no. 4; pp. 895 - 903
Main Authors Asiaban, Joshua N, Milosevich, Natalia, Chen, Emily, Bishop, Timothy R, Wang, Justin, Zhang, Yuxiang, Ackerman, Christopher J, Hampton, Eric N, Young, Travis S, Hull, Mitchell V, Cravatt, Benjamin F, Erb, Michael A
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 17.04.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ENL is a transcriptional coactivator that recruits elongation machinery to active cis-regulatory elements upon binding of its YEATS domaina chromatin reader moduleto acylated lysine side chains. Discovery chemistry for the ENL YEATS domain is highly motivated by its significance in acute leukemia pathophysiology, but cell-based assays able to support large-scale screening or hit validation efforts do not presently exist. Here, we report on the discovery of a target engagement assay that allows for high-throughput ligand discovery in living cells. This assay is based on the cellular thermal shift assay (CETSA) but does not require exposing cells to elevated temperatures, as small-molecule ligands are able to stabilize the ENL YEATS domain at 37 °C. By eliminating temperature shifts, we developed a simplified target engagement assay that requires just two steps: drug treatment and luminescence detection. To demonstrate its value for higher throughput applications, we miniaturized the assay to a 1536-well format and screened 37 120 small molecules, ultimately identifying an acyl-lysine-competitive ENL/AF9 YEATS domain inhibitor.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1554-8929
1554-8937
DOI:10.1021/acschembio.0c00124